The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients
- 1 May 1999
- journal article
- clinical trial
- Published by Springer Nature in Eye
- Vol. 13 (3) , 314-318
- https://doi.org/10.1038/eye.1999.81
Abstract
To compare the effect of adding apraclonidine 0.5% to timolol maleate 0.5% in patients with exfoliation versus primary open-angle glaucoma. Since exfoliation glaucoma is known to demonstrate higher pressures than primary open-angle glaucoma on timolol maleate therapy alone, the authors wished to determine whether apraclonidine equalised the intraocular pressure (IOP) between these two glaucomas when added to timolol maleate. We age-matched 30 consecutive exfoliation and 30 primary open-angle glaucoma patients who had an IOP > or = 22 mmHg on timolol maleate alone. Patients underwent IOP diurnal curve testing on timolol maleate twice daily alone and, 2 months later, following the addition of apraclonidine 0.5% three times daily. Statistical analysis of the IOP at each time point was by an unpaired t-test between groups. A paired t-test was used to evaluate the reduction in IOP from baseline within groups after the addition of apraclonidine. On timolol maleate alone, exfoliation patients had a higher mean IOP at 06:00 and 10:00 hours as well as a higher peak, range and standard deviation of the IOP compared with primary open-angle glaucoma patients (p < 0.05). Following the addition of apraclonidine the mean, peak and range of IOP were statistically similar between groups and only the standard deviations remained higher in the exfoliation glaucoma group (p < 0.001). The mean diurnal IOP after apraclonidine was added was 20.5 +/- 7.0 mmHg in the exfoliation glaucoma group and 20.0 +/- 3.4 mmHg in the primary open-angle glaucoma group, which was not significantly different between groups (p = 0.73). This study suggests that apraclonidine 0.5% used adjunctively with timolol maleate 0.5% solution is associated generally with similar IOP control in exfoliation and primary open-angle glaucoma patients.Keywords
This publication has 13 references indexed in Scilit:
- Diurnal Intraocular Pressure in Untreated Exfoliation and Primary Open-angle GlaucomaArchives of Ophthalmology (1950), 1997
- A 90-Day Study of the Efficacy and Side Effects of 0.25% and 0.5% Apraclonidine vs 0.5% TimololArchives of Ophthalmology (1950), 1996
- Short-term Efficacy of Apraclonidine Hydrochloride Added to Maximum-tolerated Medical Therapy for GlaucomaAmerican Journal of Ophthalmology, 1995
- Clinical Experience With the Long-term Use of 1% ApraclonidineArchives of Ophthalmology (1950), 1995
- The Efficacy of Apraclonidine as an Adjunct to Timolol TherapyArchives of Ophthalmology (1950), 1995
- Prevalence, Diagnostic Features, and Response to Trabeculectomy in Exfoliation GlaucomaOphthalmology, 1993
- Gonioscopic findings in Greek patients with exfoliation glaucomaActa Ophthalmologica, 1991
- Aqueous Flow is Reduced by the Alpha-adrenergic Agonist, Apraclonidine Hydrochloride (ALO 2145)Ophthalmology, 1988
- Long‐term prognosis of visual field in glaucoma simplex and glaucoma capsulareActa Ophthalmologica, 1985
- Dynamics of Aqueous Humorin the Syndrome of Exfoliatio with GlaucomaAmerican Journal of Ophthalmology, 1982